Last updated: January 28, 2024
Sponsor: Planned Parenthood of the St. Louis Region and Southwest Missouri
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Ulipristal acetate
levonorgestrel IUS
Clinical Study ID
NCT01539720
201201007
Ages 14-45 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women age 14-45
- Under-protected intercourse within the last five days (120 hours)
- Willingness to accept either intervention: intrauterine contraception or oralemergency contraception (EC)
- Ability and willingness to follow-up for in clinic urine pregnancy test (UPT)
- Ability and willingness to be contacted by phone for 6 and 12 month follow-up
Exclusion
Exclusion Criteria:
- Positive pregnancy test
- Non-English speaking
- Contraindication to intrauterine contraception or oral EC
- Inability or unwillingness to comply with follow-up
Study Design
Total Participants: 274
Treatment Group(s): 2
Primary Treatment: Ulipristal acetate
Phase:
Study Start date:
December 01, 2012
Estimated Completion Date:
November 30, 2018
Study Description
Connect with a study center
Atlanta Women's Center
Atlanta, Georgia 30342
United StatesSite Not Available
Indiana University School of Medicine
Indianapolis, Indiana 46202
United StatesSite Not Available
Washington University School of Medicine in St. Louis
Saint Louis, Missouri 63108
United StatesSite Not Available
Washington University in St Louis
St Louis, Missouri 63110
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.